18 Comments
User's avatar
Johnny Dollar's avatar

We've all been asking ourselves that very question.

Here in incoherent Canada, an infectious disease expert has been going around making the analogy that we should treat the ongoing and indefinite booster programs like we do antibiotics. Keep taking it until we're done.

Yes. He did.

Expand full comment
Dr Philip McMillan's avatar

The failure to understand the characteristics of COVID-19 will lead to huge suffering across the world.

Expand full comment
Andy Bunting's avatar

Failure to understand?

More like a refusal to acknowledge the reality of fact(s).

Elephant in the room?

Herd actually trampling common sense & humanity into the ground.

Expand full comment
Nat's avatar

In a society where teenage body mutilation and 'gender fluidity' is being accepted as normal/nothing to see, where military training includes workshops on proper use of pronouns, where primary school teachers boast about questioning 4 year olds about their true gender... In such a society the reality can be bent into any shape or form, including monthly boosters as a norm.

Expand full comment
Joel Smalley's avatar

4. Anticipated COVID vaccine complications.

Dwarfs 2 and 3.

Expand full comment
Janis's avatar

Dr. Theo Schetters from Netherlands analysed the same obvious correlation between vaccination campaign and excess mortality in the Netherlands and Canada. And he also could not provide a credible explanation - just making greater awareness of the issue.

The plea of Dr.McMillan to public health authorities to analyse the correlation will not result in any change in a public policy approach. Because the answer can be found in a population level dynamic between the pathogen and the host population; and vaccines are exempt from the supervision in this regard. Antibiotics have the monitoring status, but not vaccines, because antibiotics are not so investment demanding medical products.

A simplified explanation of the issue is – if a population wide antigenic pressure is exerted on a population in addition to viral loads exerted by a pandemic, you shall have excess mortality due to hampered herd immunity. This was evident in Ebola vaccination in 2016. Vaccinees died in the first weeks after the inoculation because on top of the circulating virus the body was put under pressure of additional antigenic stress, and this was in excess for the organism to sustain. Even though it could make sense in terms of immunology to vaccinate beyond the risk groups, including cohorts constituting herd immunity, during pandemic; in terms of epidemiology, it is hard to justify, unless there are some vested interests: scientific curiosity, financial gain, stupidity, etc.

Expand full comment
Dr Philip McMillan's avatar

Appreciated Janis.

Expand full comment
Joan van Wijnen's avatar

It is even disturbing, when you look at figures of Euromomo. When I do understand it correctly, the baseline is the average of the last five years. This means that the baseline in 2019 is lower then the baseline in 2022. Because the excess deaths of 2020 en 2021 are calculated in the baseline of 2022.

Expand full comment
Ted's avatar

We know that death from adverse reaction to the injections is part of the excess mortality. What we don't know is what percentage of the total that may be.

Meanwhile, we rely on anecdote, because it's almost all that we have.

During the lockdowns, local health officers mandated refusals to treat patients. This resulted in bankruptcy of unaffiliated practices.

The result of those bankruptcies was centralization of providers within corporate medical groups.

Centralization of capacity is accompanied by centralization of authority. This means that, instead of many individual decisions to treat illness or not treat illness, the decisions affecting many practitioners and patients are being made by a very few administrators.

Allow me to offer an anecdotal case study that I suspect may be representative of a wider effect;

February 2020; 62 year-old male, a sedentary smoker in a high-stress occupation with a history of mild asthma presents to his primary care physician with marked shortness of breath, productive cough and extreme fatigue. Obtains a diagnosis of bronchitis. Treatment with Aztihromyacin and low-dose injection of Kenalog (prior adverse reaction to Prednisone) was effective in reducing symptoms after ten days.

The symptoms did persist, but at a sub-acute level. The patient adapted by restricting his activity level. The patient requested a follow-up visit, seeking a second low dose injection of Kenalog to resolve the symptoms completely.

But the lockdowns were by then in force and the patient was refused a follow-up appointment, provider's scheduling persons citing shortness of breath and fatigue as "Covid symptoms." They directed the patient to seek treatment for Covid. The patient directs the schedulers to observe that he seeks a follow-up, but the corporate schedulers will not even give the physician a message. They have their orders.

The patient had no idea if he'd had Covid, but reasoned that, if so, it would have been in February. He lived with the symptoms. They persisted.

In January of 2021, the patient experienced sudden-onset complete blockage of the LAD artery, resulting in cardiogenic shock: cardiac arrest and complete respiratory collapse.

Yes, it was the "widow maker."

Considering the fact that the physician who treated the patient's bronchitis had been his primary care physician privately for thirty years before the practice was bought by a corporation, it is plausible that the physician, if still in private practice, may have chosen to see the patient in May of 2020, possibly requiring a negative PCR test prior to seeing the patient in person (that option was not offered by the corporate appointment schedulers.) It is also plausible that, when the symptoms failed to resolve, the patient would have been referred to a pulmonary care specialist by October of 2020.

It's plausible that an ECG may have been performed, either by the primary care physician or a pulmonology specialist, which might have displayed the characteristic ST spike associated with severe arterial restriction, leading to an echocardiogram that would have revealed a 90-plus percentage restriction of the LAD artery. Angioplasty might have been performed in November of 2020, preventing the myocardial infarction from occurring.

Think about it. Extrapolate with any of the myriad symptom frameworks and diagnoses that spell big trouble for human beings.

The death and injury accompanying the mass human trials of the experimental prophylactics are only the latest horror, and may be the tip of the iceberg.

Expand full comment
KIWINUT MIDSIT's avatar

Intentional evil

Expand full comment
Paul Traynor BSc's avatar

At this point, it’s a legitimate question as to whether ancestral should be included at all.

The booster I’d want would depend somewhat on my exposure history

it’s a bit of a crap shot at present

Expand full comment
Paul Traynor BSc's avatar

it's not just "pop in an updated antigen and Bob's your uncle"

All of this requires careful study.

Expand full comment
Paul Traynor BSc's avatar

Another thing that's not fully understood with bivalent mRNA vaccines is the immunological properties of 'mixed trimers' (say with 2xOG+1xBA5 or 1xOG+2xBA5) that will be major products of 'cotransfected' mRNAs. Could be better or worse for breadth.

Expand full comment
Paul Traynor BSc's avatar

in a naive individual, bivalent vaccines might make sense, however, we're talking very few people by now.

Expand full comment
Paul Traynor BSc's avatar

Not understood with bivalent mRNA vaccines is the immunological properties of 'mixed trimers' ?

Expand full comment
Paul Traynor BSc's avatar

Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine

Expand full comment
User's avatar
Comment deleted
Aug 21, 2022
Comment deleted
Expand full comment
Dr Philip McMillan's avatar

The inability to objectively review data is worrying to say the least.

Expand full comment